Conductus ships first supercon probe

Article

Conductus of Sunnyvale, CA, has made the first commercial shipmentof its SuperProtonnmr high-temperature superconducting probefor NMR spectroscopy. The probe, which is being distributed byVarian Associates as part of its Unity Inova spectrometer

Conductus of Sunnyvale, CA, has made the first commercial shipmentof its SuperProtonnmr high-temperature superconducting probefor NMR spectroscopy. The probe, which is being distributed byVarian Associates as part of its Unity Inova spectrometer system,was shipped to the National High Magnetic Field Lab at FloridaState University in Tallahassee.

SuperProtonnmr uses coils made of the high-temperaturesuperconductor yttrium barium copper oxide (SCAN 4/24/96). Conductusclaims that the probe is four times as sensitive as conventionalNMR probes, allowing the analysis of much smaller samples.

In other Conductus news, the company this month announced adistribution agreement with Nalorac, a Martinez, CA, manufacturerand distributor of NMR probes. The deal will expand the distributioncoverage available for Conductus' high-temperature superconductingprobes, as Nalorac supplies conventional NMR probes to all majorNMR manufacturers.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.